The risk that profitability will deteriorate in businesses based primarily on government-set prices, such as dispensing pharmacies, healthcare and pharmaceutical wholesaling, because higher procurement and operating costs resulting from inflation and yen depreciation cannot be passed through to selling prices. This also includes the impact of revisions to drug prices and dispensing fees.